David W. Kimberlin
Advanced in Oral Herpes

Dr. David W. Kimberlin

Pediatric Infectious Disease | Infectious Disease
1600 7th Ave S, 
Birmingham, AL 
Accepting New Patients
Advanced in Oral Herpes
1600 7th Ave S, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Kimberlin is a Pediatric Infectious Disease specialist and an Infectious Disease provider in Birmingham, Alabama. Dr. Kimberlin is rated as an Advanced provider by MediFind in the treatment of Oral Herpes. His top areas of expertise are Neonatal Herpes, Congenital Cytomegalovirus, Genital Herpes, and Cytomegalovirus Infection. Dr. Kimberlin is currently accepting new patients.

His clinical research consists of co-authoring 137 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Oral Herpes.

Specialties
Pediatric Infectious Disease
Infectious Disease
Licenses
Pediatric Infectious Diseases in AL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL

Locations

1600 7th Ave S, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss
A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss
Enrollment Status: Completed
Publish Date: October 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
Clinical Evaluation of QFlu Combo Test
Clinical Evaluation of QFlu Combo Test
Enrollment Status: Completed
Publish Date: August 06, 2021
Device Trial: Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
Device Trial: Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
Enrollment Status: Completed
Publish Date: September 09, 2020
Intervention Type: Device
View 4 Less Clinical Trials

137 Total Publications

Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood.
Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood.
Journal: The Journal of infectious diseases
Published: October 16, 2025
Similar Doctors
Experienced in Oral Herpes
Dr. Nicholas J. Van Wagoner
Infectious Disease
Experienced in Oral Herpes
Dr. Nicholas J. Van Wagoner
Infectious Disease

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.3 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nicholas Van Wagoner is an Infectious Disease provider in Birmingham, Alabama. Dr. Van Wagoner is rated as an Advanced provider by MediFind in the treatment of Oral Herpes. His top areas of expertise are Genital Herpes, HIV/AIDS, Myelitis, and AIDS Dysmorphic Syndrome. Dr. Van Wagoner is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kimberlin's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile